Therefore, METTL3 (m6A-writer) and m6A-IGF2BP2 (m6A-reader) promoted the upregulation and stabilization of CDC6 by LCAT1, which enhanced the progression of NSCLC and impaired patient survival [159] (Table 4). The gene discussed is IGF2BP2; the disease is non-small cell lung carcinoma.